Curaleaf Holdings, Inc. balance sheet CURLF

Annual Quarterly

As of Sep 30, 2026, Curaleaf Holdings, Inc. had total assets of $2.8 billion and total liabilities of $1.9 billion. Stockholders' equity was $847.0 million. It held $92.4 million in cash and investments against $928.5 million of total debt, net debt of $836.1 million. The current ratio, current assets divided by current liabilities, was 1.61.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the same quarter a year earlier.

Line	Q3 FY2026 Sep 30, 2026	Q2 FY2026 Jun 30, 2026	Q4 FY2025 Dec 31, 2025	Q4 FY2024 Dec 31, 2024	Q4 FY2023 Dec 31, 2023	Q4 FY2022 Dec 31, 2022	Q4 FY2021 Dec 31, 2021	Q4 FY2020 Dec 31, 2020
Assets
Cash	92	95	—	—	—	163 -45.5%	299 +307.0%	74
Long-term investments	—	—	—	—	2 -11.4%	3	—	—
Cash and investments	92	95	—	—	2 -98.5%	166 -44.6%	299 +307.0%	74
Receivables	77	71	74 +15.4%	64 +6.7%	60 +32.8%	45	—	—
Inventory	240	245	225 +3.7%	217 +0.5%	216 -8.0%	235	—	—
Total current assets	464	468	449 +3.3%	434 +3.8%	419 -35.8%	652	—	—
Property and equipment, net	501	506	520 -4.1%	543 -5.1%	572 -4.1%	596	—	—
Goodwill	638	633	635 +1.0%	629 +0.4%	627 +0.2%	625 +9.4%	572 +6.0%	539
Total assets	2,793	2,814	2,845 -3.5%	2,950 -4.7%	3,097 -9.3%	3,415 +10.0%	3,105 +31.3%	2,366
Liabilities and equity
Accounts payable	64	60	75 -5.6%	79 -0.2%	79 -1.8%	81	—	—
Total current liabilities	288	307	294 -24.1%	388 -21.5%	494 -0.6%	497	—	—
Total liabilities	1,946	1,947	2,005 +2.5%	1,956 +1.6%	1,925 -4.4%	2,014 +39.8%	1,440 +46.2%	985
Stockholders' equity	847	867	756 -12.2%	861 -18.0%	1,051 -17.9%	1,280	—	—
Debt
Debt due within a year	46	41	36 -64.9%	102 +157.7%	39 -23.9%	52 -88.1%	436 +49.6%	292
Long-term debt	583	571	513 +9.9%	467 -14.8%	548 -3.9%	571	—	—
Lease liabilities	299	298	278 -2.4%	285 -3.6%	296 -3.4%	306 -4.2%	319 +10.6%	289
Total debt	928	909	827 -3.1%	854 -3.4%	884 -4.9%	929 +22.9%	756 +30.2%	580
Net cash	-836	-815	—	—	-881 -15.5%	-763 -67.2%	-456 +10.0%	-507
Ratios
Current ratio	1.61x	1.52x	1.52x	1.12x	0.85x	1.31x	—	—
Debt to equity	1.10x	1.05x	1.09x	0.99x	0.84x	0.73x	—	—
Debt to EBITDA	—	—	3.72x	3.33x	3.70x	4.20x	—	—
Return on equity	—	—	-30.55%	-25.01%	-26.76%	-28.92%	—	—
Return on assets	—	—	-8.12%	-7.30%	-9.08%	-10.84%	—	—
Book value per share	3.20	3.28	—	1.15	1.43	—	—	—

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry: Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as: CURLF (OTC)
Fiscal year ends: December 31
Incorporated in: British Columbia, Canada
Headquarters: Stamford, CT
SEC filer status: Large accelerated filer
SEC CIK: 1756770

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.